We report our clinical experience with a new orally administered
gastrointestinal contrast agent, simethicone coated cellulose
suspension (7.5 mg/mL) (SonoRx@, Braceo Diagnostics, Inc.,
Princeton, NJ) during phase I and phase l l clinical trials.
Please click on the PDF file to view this article. You will need
to have Adobe Acrobat Reader on your computer. If you do not,
please download a free version from www.adobe.com.